|
|
|
18 Mar 2008 |
Targeted Genetics Announces Completion of Dosing for the Phase 1/2 Clinical Trial of tgAAC94 for Inflammatory Arthritis
|
|
17 Mar 2008 |
Archemix Announces Initiation of Phase 2 Trial for Aptamer Product Candidate ARC1779 in Patients with TTP, a Rare, Life-Threatening Blood Disorder
|
|
14 Mar 2008 |
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
|
|
13 Mar 2008 |
AstraZeneca signs drug delivery collaboration
|
|
13 Mar 2008 |
Arrowhead Subsidiary, Calando Pharmaceuticals, Submits IND for Clinical Trial with Targeted, Nano-Delivered RNAi Therapeutic for Cancer
|
|
12 Mar 2008 |
Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug
|
|
12 Mar 2008 |
Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products
|
|
11 Mar 2008 |
Cardium's Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
|
|
06 Mar 2008 |
Oncolys BioPharma and Medigen Biotechnology Enters Strategic Alliance and License Agreement to Develop and Commercialize Telomelysin(R)(OBP-301) for a Potential New Treatment for Solid Tumors
|
|
04 Mar 2008 |
Pluristem Submits Pre-IND Application in Germany to Initiate Clinical Trials of PLX-PAD for Peripheral Artery Disease
|
|
29 Feb 2008 |
Phase II Clinical Trial of ALN-RSV01 Demonstrates Statistically Significant Anti-Viral Efficacy with an Approximately 40% Reduction in RSV Infection Rate and 95% Increase in Infection-Free Subjects
|
|
28 Feb 2008 |
AVONTEC announce results of a multiple dose clinical proof of concept study with its drug candidate AVT-01 decoy ODN in asthmatic patients
|
|
26 Feb 2008 |
Prochymal(TM) Demonstrates Lasting Benefit in Heart Attack
|
|
25 Feb 2008 |
Harvest Technologies announces patient enrollment has begun for a clinical trial in India using autologous adult stem cells to treat patients with non-reconstructible Critical Limb Ischemia (CLI) due to Peripheral Arterial Occlusive Disease (PAOD)
|
|
15 Feb 2008 |
OncoGenex Reports Lead Drug Candidate OGX-011 Achieved Primary Endpoint in Phase 2 Trial with Second-Line Chemotherapy for Prostate Cancer
|
|
14 Feb 2008 |
Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
|
|
13 Feb 2008 |
Introgen's p53 Immunotherapy INGN 225 Begins Randomized, Controlled Clinical Trial in Patients with Small Cell Lung Cancer
|
|
12 Feb 2008 |
Ophthotech Enrolls Its First Patient in a Phase I Anti-PDGF Macular Degeneration Trial
|
|
09 Feb 2008 |
VGX Pharmaceuticals Announces the IND Filing of VGX-3200, a Novel DNA Therapy That Utilizes GHRH for the Treatment of Cancer Cachexia and Anemia
|
|
07 Feb 2008 |
Alnylam Reports Pre-clinical Progress with RNAi Therapeutics in Neurological Disease
|
|
06 Feb 2008 |
Insception Biosciences Begins Human Clinical Trials of Stem Cell Treatment That Could Replace Bone Marrow Transplants
|
|
30 Jan 2008 |
Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
|
|
29 Jan 2008 |
Topigen Pharmaceuticals Initiates European Phase 2 Clinical Study of TPI ASM8 in Patients with Asthma
|
|
23 Jan 2008 |
Alnylam Reports Positive Phase II Data for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
|
|
22 Jan 2008 |
MolMed gets regulatory approval to start a Phase III trial in Italy of its TK therapy for high risk acute leukaemia
|
|
18 Jan 2008 |
StemCells, Inc. Provides Batten's Clinical Trial Update
|
|
17 Jan 2008 |
Clinical Trial to Treat Rare Skin Disorder With siRNA Technology
|
|
10 Jan 2008 |
Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer
|
|
08 Jan 2008 |
Sangamo BioSciences Initiates Phase 2 Clinical Trial of ZFP Therapeutic in Stem Cell Mobilization
|
|
07 Jan 2008 |
Tacere Therapeutics Eenters Collaborationa and License Agreement With Pfizer to Develop and Commercilize RNAi Hepatitis C Drug
|
|
07 Jan 2008 |
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
|
|
27 Dec 2007 |
Leiden University Medical Center and Prosensa B.V. Announce New England Journal of Medicine Publication of First Successful Clinical Study with RNA-based Therapeutic PRO051 in Duchenne Muscular Dystrophy
|
|
20 Dec 2007 |
Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
|
|
18 Dec 2007 |
Epeius Biotechnologies gains commercial approval for Rexin-G(R), a tumor-targeted gene-based medicine for metastatic cancer
|
|
18 Dec 2007 |
Year-end clinical trial update
|
|
13 Dec 2007 |
Oxford biomedica initiates Phase I/II trial of prosavin (R) gene-based treatment for parkinson's disease
|
|
13 Dec 2007 |
Alnylam Reports Continued Progress in Clinical Development of ALN-RSV01 for the Treatment of Respiratory Syncytial Virus (RSV) Infection
|
|
12 Dec 2007 |
NeuroSearch's associated company NsGene A/S starts Phase Ib clinical study with NsG0202 for the treatment of Alzheimer's disease
|
|
12 Dec 2007 |
Gene A/S begins Phase Ib clinical trial with NsG0202 for the treatment of Alzheimer's disease
|
|
12 Dec 2007 |
Ceregene Presents Long-Term Follow-Up from Phase 1 Trial of CERE-120 in Parkinson's Disease
|
|
10 Dec 2007 |
Sangamo BioSciences Announces Presentation of Data for ZFP Therapeutic for Glioblastoma at American Society for Hematology Meeting
|
|
10 Dec 2007 |
Osiris Therapeutics Reports Positive Results for Prochymal(TM) as
|
|
05 Dec 2007 |
Senesco Technologies Initiates Preclinical Studies for Cancer Target
|
|
04 Dec 2007 |
Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
|
|
03 Dec 2007 |
Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
|
|
28 Nov 2007 |
Geron initiates clinical trial of telomerase inhibitor drug in patients with multiple myeloma
|
|
27 Nov 2007 |
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
|
|
27 Nov 2007 |
Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis
|
|
27 Nov 2007 |
Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases
|
|
26 Nov 2007 |
Targeted Genetics Announces That FDA Has Removed Hold on Phase I/II Clinical Trial of tgAAC94 for Inflammatory Arthritis
|
| |
|
Results 101 - 150 of 591 |
